Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-453-4 | CAS number: 107-02-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
"Acrolein is irritating and corrosive to skin and eyes in laboratory animals and humans."
"Several studies show that acrolein causes sensory irritation of the respiratory tract after inhalation."
"The RD50 of acrolein, the concentration causing 50% reduction in respiratory rate, amounted to 2.4 - 6.6 mg/m³ in mice and 9.2 and 21.7 mg/m³ in rats." quotation from European Union Risk Assessment Report Acrylaldehyde (EU, 2001)
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (corrosive)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Additional information
Acrolein has been the subject of a risk assessment carried out under Community Regulation (EEC) No 793/93 (EU, 2001). The key information on skin and eye irritation/corrossion as well as on respiratory irritation of acrolein as stated are quotations taken from this EU Risk Assessment. The information on irritaing/corrosive activity of acrolein given in the EU Risk Assessment correspond to the greatest extend to further assessments carried out under other international and national programmes published after finalisation of the EU Risk Assessment Report 2001 (World Health Organization, International Programme on Chemical Safety (IPCS), Concise International Chemical Assessment Document of Acrolein, CICADS 43 (WHO, 2002); United States Environmental Protection Agency, Toxicological Review of Acrolein (US-EPA, 2003); United States Agency for Toxic Substances and Desease Registry, Toxicological Profile for Acrolein (US ATSDR, 2007); United States Environmental Protection Agency, Reregistration Eligibility Decision (RED) Document for Acrolein (US-EPA, 2008)). Supplementary information to EU, 2001 regarding a study on respiratory irritation (Morris et al., 2003 as quoted in US ATSDR, 2007) has been considered:
1. European Union Risk Assessment Report of Acrolein (EU, 2001)
“Acrolein is irritating and corrosive to skin and eyes in laboratory animals and humans.
In humans threshold levels for various local effects of acrolein were as follows: slight eye irritation (subjectively reported) was apparent after exposure to 0.14 mg/m³ for 5 minutes, 0.48- 0.80 mg/m³ was the odour threshold, continuous exposure to 0.69 mg/m³ resulted in considerable eye and nose irritation after 10 - 20 minutes and a significantly decreased respiratory frequency after 40 minutes of exposure, and exposure to 1.9 mg/m³ for 10 minutes resulted in extreme irritation of all mucosal surfaces.” quotation from EU, 2001, p82
In Detail:
Animal studies:
“Exposure to acrolein vapour concentrations between 1.9 and 2.6 ppm for 4 hours caused slight irritation of the eyes in rabbits (Mettier, 1960). Exposure of rabbits to 0.6 ppm acrolein vapour (1.4 mg/m³), for 30 days, 4 hours/day, 5 days a week produced no eye irritation (Mettier et al., 1960).”
“Acrolein is stated to be corrosive to the skin and eyes of rabbits and 1 % solutions of acrolein give rise to serious eye and skin damage (Albin, 1975, no reports available).”
“Reduction of the ciliary movement in tracheas was observed in in vitro tests with tracheal preparations from rabbits, cattle and sheep (Guillerm et al., 1967; Kensler et al., 1963; Sisson et al., 1991), and in an in vitro/in vivo test with hens (Battista et al., 1970).
General appearance and behaviour of the rats exposed to atmospheres containing 0.25, 0.67 or 1.40 ppm acrolein in air (nature of the substance is unknown), 6 h/day for 1 or 3 days in a nose only inhalation chamber were essentially normal during and after exposure. No clinical signs of eye, nose or respiratory irritation were reported. Microscopic examination revealed, however, slight treatment-related histopathological changes in the respiratory/transitional but not in the olfactory epithelium of the nose of rats exposed to 0.25 or 0.67 ppm acrolein. The 1.40 ppm group was not examined histologically (Cassee et al., 1996).
Several studies show that acrolein causes sensory irritation of the respiratory tract after inhalation.
The RD50 of acrolein, the concentration causing 50% reduction in respiratory rate, amounted to 2.4 - 6.6 mg/m³ in mice (nature of the substance is unknown) (IPCS, 1992). In rats RD50 values of 9.2 and 13.7 mg/m³ are found (nature of the substance is unknown) (IPCS, 1992, Cassee et al., 1996).” quotations from EU, 2001, p58 and p60
Human Data:
Accidental Exposure
“A few cases of accidental exposure to acrolein and a suicidal attempt with acrolein ingested in orange juice were described. Effects were observed on the primary exposure sites and were characterised by signs of severe irritation, finally resulting in corrosion, of skin and eyes and of the mucosal layer of stomach and respiratory tract.” quotation from EU, 2001, p58
Volunteer Studies
“Several studies with volunteers were performed to establish threshold levels for odour perception and recognition, and for effects on eyes, nose and respiratory tract. It is noted that many of these studies are of older date and the analytical methods used are often unspecific or poorly described.” quotation from EU, 2001, p58
Irritant Effects, Dermal Exposure
“Patch tests were conducted with acrolein in ethanol at concentration of 0.01, 0.1, 1 and 10% on groups of 8, 10, 48 and 20 volunteers respectively (Lacroix et al., 1976). At 1% positive reactions were recorded in 6 out of 48 persons (12.5%), four cases of serious oedema with bullae and two with erythema. At 10% all subjects (n = 20) showed skin effects with bullae, necrosis, inflammatory cell infiltrate and papillary oedema. No reactions were observed at 0.01 (n = 8) or 0.1% (n = 10). These data cannot be used to establish a no-effect-level for human skin irritation, because the duration of exposure and the onset of symptoms were not reported. In addition, at lower concentrations the number of volunteers per group was too small.” quotation from EU, 2001, p60
Irritant Effects, Inhalation Exposure
“Several experiments were performed to examine the irritant effects of acrolein vapour on eyes, nose and respiratory tract. In a study of Weber-Tschopp et al. (1977) three experiments were conducted”:
“A. continuous exposure during 35 minutes to a gradually increasing concentrations from 0 to 0.6 ppm, followed by a constant exposure to 0.6 ppm for 5 minutes (n = 54)
B. exposure during 60 minutes to a constant concentration of 0.3 ppm (n = 46)
C. four exposures (1.5 minutes) to increasing concentrations of 0.15, 0.3, 0.45 and 0.6 ppm with 8 minutes recovery time between the exposures (n = 42)
In experiment A subjective irritation of eyes and nose, annoyance and eye blinking rate increased, and the respiratory rate decreased with increasing acrolein vapour concentration. At the following concentration the effects were statistically significant: eye irritation at 0.09 ppm (0.21 mg/m³), nose irritation at 0.15 ppm (0.34 mg/m³), increase of eye blinking rate at 0.26 ppm (0.59 mg/m³) and decrease of respiratory rate at 0.6 ppm (1.3 mg/m³). In experiment B considerable eye and nose irritation was recorded after 10 to 20 minutes, and a significant decrease in the respiratory frequency after 40 minutes exposure to a constant acrolein vapour concentration of 0.3 ppm (0.69 mg/m³). Comparing the effects caused by discontinuous exposure (experiment C) with continuous exposure (experiment A) it is concluded that irritation to the eyes and nose is significantly more severe at continuous exposure, indicating that the effects were dependent on the exposure time.”
“Volunteers exposed to acrolein vapour for 5 min recorded the eye irritation degree on a scale of 0 to 2 (0 = none, 1 = medium, 2 = severe). The irritation indices amounted to 0.471 at 0.06 ppm (0.14 mg/m³), 1.2 at 1.3 - 1.6 ppm and 1.5 at 2.0 - 2.3 ppm (Darley et al., 1960).
Sim and Pattle (1957) examined the irritant effects of acrolein in volunteers exposed to atmospheres containing acrolein concentrations of 0.83 ppm for 10 min and 1.2 ppm for 5 min. Acrolein was extremely irritating to all exposed mucosal surfaces. At 0.83 ppm lacrimation occurred within 20 seconds, at 1.2 ppm already after 5 seconds.” quotations from EU, 2001, p55, p60
Odour Threshold
“Leonardos (1969) found an odour threshold, defined as the first concentration at which all persons (n = 4) recognised the odour, of 0.21 ppm (0.48 mg/m³). Plotnikova reported an odour threshold for acrolein of 0.35 ppm (0.8 mg/m³) (Plotnikova 1957, abstract, no details).” quotations from EU, 2001, p58
2. Agreement with further International Reports and Studies Published after Finalisation of the EU Risk Assessment Report 2001
No substantial deviations in characterisation of these intrinsic properties in the EU Risk Assessment Report 2001 to WHO, 2002; US-EPA, 2003, US ATSDR, 2007 and US-EPA, 2008.
Due to the large number of studies on the irritating properties of acrolein available and a slightly deviating selection of studies referred in the individual international reports, the reported range of RD50values slightly deviate between the reports, e.g. RD50 for rats of 10.5 to 21.7 mg/m³ reported in US-EPA, 2003 whereas values of 9.2 and 13.7 mg/m³ are referred in the EU Risk Assessment Report 2001. Furthermore, the focus of the different international reports are non-identically. Therefore, the way of data preparation and elaborateness are different, especially in US-EPA, 2003, US ATSDR, 2007 and US-EPA, 2008 in comparison to the EU Risk Assessment Report 2001. However, within the individual reports the judgement on irritation/corrosion activity of acrolein does not substantially deviate.
3. Substantial Disagreements in Comparison to further International Reports to European Union Risk Assessment Report 2001
None
4. Additional Aspects in further International Reports
US ATSDR, 2007: “Significantly decreased respiratory rates were observed in allergic airway-diseased mice compared to non diseased mice exposed to 0.3 ppm acrolein for 10 minutes (Morris et al. 2003).” Quotation from US ATSDR, 2007, p35
5. Additional Information in Newer Studies, not Included in the European Union Risk Assessment Report 2001 or further Cited International Reports
None substantial
The following information is taken into account for hazard / risk assessment:
Acrolein is irritating and corrosive to skin and eyes in laboratory animals and humans.
Several studies show that acrolein causes sensory irritation of the respiratory tract after inhalation.
The RD50 of acrolein, the concentration causing 50% reduction in respiratory rate, amounted to 2.4 - 6.6 mg/m³ in mice and 9.2 and 21.7 mg/m³ in rats.
Justification for selection of skin irritation / corrosion endpoint:
see European Union Risk Assessment Report of Acrolein (EU, 2001)
Justification for selection of eye irritation endpoint:
see European Union Risk Assessment Report of Acrolein (EU, 2001)
Effects on skin irritation/corrosion: corrosive
Effects on eye irritation: corrosive
Effects on respiratory irritation: highly irritating
Justification for classification or non-classification
Legally binding harmonised classification as given in REGULATION (EC) No 1272/2008 Annex VI
Table 3.1 (CLP): Skin Corr.1B H314
Table 3.2 (Annex I of Directive 67/548/EEC): C; R34
In addition to classification for inhalation toxicity, according to Annex I No. 3.1.2.3.3 (CLP) the test substance acrolein should be classified as:
EUH071 Corrosive to the respiratory tract
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.